Document is current
Any future updates will be listed below
-
Authors
Krishna, Chirag
Chiou, Joshua http://orcid.org/0000-0002-4618-0647
Sakaue, Saori http://orcid.org/0000-0003-3618-9717
Kang, Joyce B.
Christensen, Stephen M. http://orcid.org/0000-0002-3618-6420
Lee, Isac
Aksit, Melis Atalar
Kim, Hye In
von Schack, David
Raychaudhuri, Soumya http://orcid.org/0000-0002-1901-8265
Ziemek, Daniel
Hu, Xinli http://orcid.org/0009-0000-3333-3459
- License Information
-
More Information
Article History
Received: 18 August 2023
Accepted: 15 July 2024
First Online: 31 July 2024
Competing interests
: C.K., J.C., I.L., M.A.A., H.I.K., S.M.C., D.V.S., D.Z., and X.H. are employees and/or stockholders of Pfizer. S.R. is a scientific advisor to Pfizer, Janssen, and Sonoma Biotherapeutics, a founder of Mestag Therapeutics, and a consultant for Abbvie and Sanofi. The remaining authors declare no competing interests.
